Meet the founder searching for the ‘holy grail’ of cancer treatment Founder profile Jennifer Sieg speaks with Hilmar Warenius about how his discovery of a new type of cancer treatment could be well on its way to revolutionising the pharmaceutical industry
Angle agrees deal with Astrazeneca for tech to kill cancer cells Pharma This is expected to be driven by an increase in the use of combination therapy for the treatment of drug-resistant cancers and the need for novel targeted medicines for cancer treatment.